Left ventricular outflow tract (LVOT) obstruction has been classically observed in hypertrophic cardiomyopathy in which the LVOT obstruction is associated with asymmetric septal hypertrophy producing a systolic pressure gradient across the LVOT.
1
Basal septal hypertrophy (BSH) with hypertension may result in dynamic LVOT obstruction as well. 2, 3 It was suggested that regional hypertrophy may be related to enhanced ventricular dynamics. 4 We have previously observed a significant correlation between decreased LVOT area and LVOT gradients in patients with hypertrophic cardiomyopathy using real-time three dimensional echocardiography. 5 In hypertrophic cardiomyopathy, left ventricular (LV) wall thickening is associated with a nondilated and hyperdynamic chamber (often with systolic cavity obliteration) in the absence of another cardiac or systemic disease (e.g., hypertension or aortic stenosis) capable of producing the magnitude of hypertrophy evident, and independent of whether or not LVOT obstruction is present. 1 Dobutamine stress was used in 24 hypertensive patients (mean age 5678 years; 11 women) with BSH and 20 normal controls (mean age 5479 years; seven women) to compare both groups. The study group was selected among the hypertensive patients who were seen in our outpatient clinic and resting echocardiographic examination had shown BSH and diastolic dysfunction as previously reported. 6 Patients with previously diagnosed hypertension as well as using one or more antihypertensive medication were included to the study. All patients were on ACE inhibitor, 17 patients on additional diuretics and only one on beta-blocker. Secondary causes of hypertension were excluded by the attending physician after complete medical history, physical examination, routine biochemical analyses of blood and urine, hormonal analyses and abdominal ultrasound. Further investigation was carried out only when abnormalities were found in these analyses or when other symptoms or signs of secondary hypertension were present. No patient showed any cardiac or systemic disease involving LV myocardium besides hypertension. The patients were included to the study as previously described inclusion criteria. 2 The study was approved by the Institutional Review Board.
Resting echocardiography was performed using Acuson 128 XP10 device (Mountain View, CA, USA) equipped with a variable-frequency phased-array transducer (2.5-3.5-4.0 MHz) and Doppler tissue imaging (DTI) capabilities. Fractional shortening and ejection fraction were measured by M-Mode echocardiography and Teichholz method, respectively. Left ventricular mass was calculated by the Penn Convention geometric formula. 7 Pulsed DTI was performed at transducer frequencies of 3.5-4.0 MHz, adjusting spectral Doppler filters until a Nyquist limit of 15-20 cm/s was reached, and using minimal adequate gain. The sample volume was subsequently placed on the basal septal segment wall to determine regional tissue systolic and diastolic velocities from the apical four-chamber view. The apical view was chosen in order to assess LV wall motion to minimise the incidence angle between tissue Doppler beam and LV longitudinal motion. Both groups underwent stress echocardiography according to the protocol as reported previously. 2 Data comparison of both groups was made by unpaired t-test. The level of Po0.05 was considered statistically meaningful.
The interventricular septum showed BSH in the patients, with a mean thickness of 1.5570.2 cm compared to normals (1.0370.1 cm, Po0.001), while midseptal thickness was similar (1.0970.1, 1.0670.1 cm, respectively). There was no difference in ejection fraction and myocardial mass between BSH patients (5873%, 204724 g) and normals (5674%, 201732 g, respectively). Mean LVOT diameter was narrower in the patient group (1.3370.2 cm) compared to the control group (1.8570.2 cm, Po0.001). Transmitral early/late diastolic filling velocities was lower in BSH patients than normals (0.7270.2, 1.270.1 ms, Po0.001) and mean deceleration time was longer in BSH patients than normals (275720, 172713 ms, Po0.001, respectively).
Stress echocardiography was successfully completed in all patients and control subjects. No patient developed a ST segment shift on the standard 12-lead ECG recorded or any new wall motion abnormality suggesting ischaemia at stress. Left ventricular rate-pressure product at peak stress was higher in BSH (23 32674388) than normals (17 59272409, Po0.001). Basal septal DTI systolic velocities were similar in BSH (771.7 cm/s, Figure 1 ) and normals (6.871.2 cm/s, respectively) at rest. At peak stress, maximum basal septal DTI systolic velocities were significantly increased in the BSH patients (1773 cm/s, Figure 1 ) compared to normals (13.772.5 cm/s, Po0.001). Regional BS early and early/late diastolic tissue velocities were unchanged under stress, while late diastolic tissue velocities were increased.
The present study describes hyperdynamic wall motion of the regional hypertrophy at peak pharmacologic stress using DTI in the hypertensive BSH. Although evaluation of ultrasonographic septal thickness has some technical problems, isolated septal hypertrophy has long been observed frequently and early structural adaptation in hypertensive patients. 8 Echocardiographic features in BSH was found different from HCM, an autopsy was performed in one patient and the hypertrophy was identified, although results of microscopic examination showed no fibre disarray. 9 We previously observed that a decreased LV basal cavity volume possibly due to regional hypertrophy of basal segment in secondary LV hypertrophy by real-time three dimensional echocardiography. 10 Increased LVOT gradients by pharmacologic stress were shown echocardiographically in a group of healthy elderly with protruding angulated septum similar to that in BSH with hypertension. 11 It was suggested that the regional hypertrophy may be secondary or contributory to the enhanced ventricular dynamics differently from primary cardiomyopathy. 4 All of the patients in the current study were on ACE inhibitor and some of them on additional diuretics and one on beta-blocker. Al-Nasser et al. 3 have shown that beta-blocker therapy provides a LVOT gradient reduction at peak stress in elderly BSH patients (two-thirds hypertensive), and have speculated that negative inotropic effect similar to that in HCM 12 may be effective on LVOT gradient reduction.
The limitation of the study protocol was noninvasive, so we do not have information on the presence of coronary artery disease; its presence seems unlikely in view of the high LV rate-pressure product achieved with the absence of ST segment shift and the lack of any localised wall motion abnormalities to appear at peak stress.
In conclusion, peak pharmacologic stress causes higher systolic velocities on basal septal tissue in the hypertensive patients with BSH than control group. This suggests pharmacologic stress may produce a hyperdynamic response on the regional hypertrophied myocardium, which may cause dynamic LVOT obstruction in hypertensive patients. What is known about topic K Basal septal hypertrophy in hypertensive patients may result in dynamic LVOT obstruction which is classically observed in patients with hypertrophic cardiomyopathy K Results of microscopic examination had shown no fibre disarray in basal septal hypertrophy K Some observations support that focal hypertrophy may be secondary or contributory to the enhanced ventricular dynamics differently from primary cardiomyopathy K In BSH patients with dynamic LVOT obstruction on stress echocardiography, beta-blockade may represent a beneficial therapeutic approach
What this study adds K Our findings provide a quantitative data by Doppler tissue imaging that basal septal myocardium gives a hyperdynamic response to dobutamine stress K Stress-induced hyperdynamic function of LV basal septum, which is the closest part of the septum to increased afterload may be related to LVOT obstruction in hypertensive patients with basal septal hypertrophy
